Portfolio Companies
Through a sponsored research agreement with Tufts University, Allied Minds has established BA Logix Inc. to develop and commercialize a novel computational methodology applicable to imaging and compression technologies resulting in extremely fast and efficient implementations.
Allied Minds has teamed with the University of Michigan to establish Biotectix LLC to develop and commercialize novel bioactive conductive polymer electrodes and coatings tailored to enhance a wide variety of medical devices and result in a fully integrated electrode-tissue interface.
Allied Minds has teamed with Washington University to establish Cephalogics, LLC to develop and commercialize a novel wearable neuroimaging device for continuous functional mapping and monitoring of the human brain.
Harvard University, Northeastern University, and Allied Minds established CryoXtract Instruments, LLC to develop and commercialize a novel technology for extracting aliquots from frozen biological samples without thawing, maintaining integrity of the stored samples for future use, and significantly improving throughput of the sample aliquotting process.
Allied Minds has teamed with the Science & Technology Corporation of the University of New Mexico to commercialize a non-invasive blood test for the early detection of endometrial cancer.
Allied Minds has teamed with Wayne State University to establish GliaGen, LLC which will specialize in novel diagnostic and therapeutic technologies specifically tailored to treat neurodegenerative diseases.
Allied Minds has teamed with the University of Colorado to commercialize a non-invasive method to provide quantitative information on complex blood flow in the treatment of vascular disease.
Allied Minds has teamed with the University of Missouri-Columbia to establish LifeScreen to bring new non-invasive breast cancer screening technology to the market.
Allied Minds has teamed with the University of Nebraska Medical Center to commercialize a novel protein purification technology for drug development and production.
Allied Minds has partnered with University of California, Davis to establish RF Biocidics, Inc. to develop and commercialize novel disinfectant and disinfestant technology representing a “cleantech” approach to eliminate undesirable pathogens and insects without the use of dangerous chemicals or radiation.
Allied Minds has teamed with the Weill Medical College of Cornell University to develop and commercialize a new patient salt intake monitoring system, not requiring the use of laboratory facilities.
Harvard and Allied Minds established SiEnergy Systems, LLC, to develop and commercialize novel solid oxide fuel cell (SOFC) technology applicable to a wide variety of power applications.
Allied Minds has teamed with New York University to establish Spin Transfer Technologies, LLC to develop and commercialize novel magnetoresistive random access memory (MRAM), a form of non-volatile computer memory.